The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).
 
Nedim Turan
No Relationships to Disclose
 
Timucin Cil
No Relationships to Disclose
 
Mehmet Artac
Honoraria - Amgen; Bayer; Merck; Pfizer; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Merck; Roche
 
Ilhan Hacibekiroglu
No Relationships to Disclose
 
Ahmet Taner Sümbül
No Relationships to Disclose
 
Dogan Uncu
No Relationships to Disclose
 
Akin Ozturk
No Relationships to Disclose
 
Abdurrahman Isikdogan
No Relationships to Disclose
 
Sema Sezgin Goksu
No Relationships to Disclose
 
Ozturk Ates
No Relationships to Disclose
 
Nuri Karadurmus
No Relationships to Disclose
 
Mehmet Ali Nahit Sendur
No Relationships to Disclose
 
Lokman Koral
No Relationships to Disclose
 
Mehmet Bilici
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gen (Inst)
 
Umut Demirci
Honoraria - Abdi Ibrahim; AstraZeneca; AstraZeneca; BMS Turkey; CTGEN; Daiichi Sankyo/Astra Zeneca; Gen; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini; Merck Serono; MSD; Novartis; Roche; Sandoz
Consulting or Advisory Role - Gilead Sciences; Menarini; MSD; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gen; Pfizer
 
Emir Celik
No Relationships to Disclose
 
Cagatay Arslan
Consulting or Advisory Role - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Speakers' Bureau - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Research Funding - Roche, Novartis, BMS, Merck, MSD, Astra Zeneca, Nektar, Johnson &Johnson, Lilly, Amgen, Incyte, Bayer, Yuhan, Henlius, Pfizer, Biontech, Genmab, Beigene, GSK
 
Haci Mehmet Turk
No Relationships to Disclose
 
Bekir Hacioglu
No Relationships to Disclose
 
Mahmut Gumus
Honoraria - Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - Amgen (Inst); MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer